DPIIT recognised startup Government of India
Startup India
Jips Pharmaceuticals Private Limited - pharma in Chandigarh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹27.63 Cr
▲ 19% YoY
Net profit · FY 2023
₹89.33 Lakh
Net margin 3.2%
EBITDA · FY 2023
₹1.44 Cr
EBITDA margin 5.2%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
9 yrs
Est. 2017
Employees · EPFO
16
Provident fund records
Directors on board
4
As per MCA filings
About Jips Pharmaceuticals Private Limited
Data last updated:
Jips Pharmaceuticals Private Limited is a private limited company based in Chandigarh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 January 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24304CH2017PTC041344. Its GSTIN is 03AADCJ8712C1Z1 (Punjab).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors including Irvandeep Kaur and Supreet Singh.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at 828 Sector – 16 D, Chandigarh, India – 160015.
As per the financials filed for FY 2023, the company reported a revenue of ₹27.63 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹89.33 Lakh (net margin 3.2%) and EBITDA of ₹1.44 Cr (EBITDA margin 5.2%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 59% over five years.
The company has about 16 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: JIPS Pharmaceuticals. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 1 case is pending.
Jips Pharmaceuticals Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-PB-20-0025407). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jipspharmaceuticals.com.
Company details
CIN U24304CH2017PTC041344
Registration Number 041344
Incorporation Date 13 January 2017
ROC Chandigarh
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
MSME Classification Small
Udyam Registration UDYAM-PB-20-0025407
Recognitions & Rankings of Jips Pharmaceuticals
MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-PB-20-0025407
Contact details
Jips Pharmaceuticals Private Limited's registered office is in Chandigarh, Chandigarh. Its website is jipspharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address828 Sector – 16 D, Chandigarh, India – 160015
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Jips Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Jips Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Jips Pharmaceuticals operates one associated brand: JIPS Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies a range of pharmaceutical formulations and tablets. | jipspharmaceuticals.com |
Business activity
The main business activity of Jips Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Jips Pharmaceuticals Private Limited, buy the company report.
Financials of Jips Pharmaceuticals Private Limited
FY 2023 filings availableJips Pharmaceuticals Private Limited reported revenue of ₹27.63 Cr (up 19% YoY) for FY 2023.
Revenue · FY 2023
₹27.63 Cr ▲ 19%
Net profit · FY 2023
₹89.33 Lakh margin 3.2%
EBITDA · FY 2023
₹1.44 Cr margin 5.2%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 29%
5 years · compounded
▲ 59%
EBITDA CAGR growth
1 year
▼ 21%
3 years · compounded
▲ 59%
5 years · compounded
▲ 46%
Revenue has grown at a compounded annual rate (CAGR) of 59% over five years, including 19% growth in the latest year. EBITDA fell 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹27.63 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.44 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹89.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.2% | ||||
| Net Profit Margin | 3.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jips Pharmaceuticals Private Limited, buy the company report.
Board of directors of Jips Pharmaceuticals Private Limited
Jips Pharmaceuticals has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Irvandeep Kaur | Director | 17 Jan 2017 | 9 Years 9 Months | Current |
| Supreet Singh Also directs: Rudrakyra Production LLP, Tas Derma Private Limited, Mind in Peace Private Limited and 3 more | Director | 17 Jan 2017 | 9 Years 9 Months | Current |
| Jagdeep Singh Also directs: Rudrakyra Production LLP, Tas Derma Private Limited, Mind in Peace Private Limited and 3 more | Director | 13 Jan 2017 | 9 Years 9 Months | Current |
| Parvinder Jit Singh | Director | 13 Jan 2017 | 9 Years 9 Months | Current |
Peer comparison
Jips Pharmaceuticals Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Synac Pharmaceuticals Private Limited | ₹27.79 Cr (FY 2025) | 311.0% | Hyderabad, Telangana, India | |||
| Anthea Pharma Private Limited | ₹27.78 Cr (FY 2025) | 516.0% | Hyderabad, Telangana, India | |||
| Lifesticks Pharmaceuticals Private Limited | ₹27.68 Cr (FY 2025) | 196.0% | Roorkee, Uttarakhand, India | |||
| Sain Medicaments Private Limited | ₹27.64 Cr (FY 2025) | 4.0% | Telangana, India | |||
| Jips Pharmaceuticals Private Limitedthis company | ₹27.63 Cr (FY 2023) | ₹89.33 Lakh | 3.2% | 19.0% | 16 | Chandigarh, India |
| Quixotic Pharma Private Limited | ₹27.58 Cr (FY 2025) | -8.0% | Punjab, India | |||
| Augxen Pharma Private Limited | ₹27.52 Cr (FY 2025) | 134.0% | Bharuch, Gujarat, India | |||
| Cirex Pharmaceuticals Private Limited | ₹27.51 Cr (FY 2025) | 487.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Jips Pharmaceuticals Private Limited, buy the company report.
Auditor
Jips Pharmaceuticals Private Limited is audited by VIJAY S MATHUR & CO for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIJAY S MATHUR & CO | FY 2023 | 03846N |
Shareholding
The shareholding of Jips Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Jips Pharmaceuticals Private Limited, buy the company report.
Legal cases
Jips Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Jips Pharmaceuticals, 1 filed against it. 1 case is pending and 2 are disposed.
Total cases
3
Filed by the company
2
Filed against the company
1
Pending
1
Disposed
2
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against M/S Zetaca Pharmaceuticals Pvt Ltd and 3 others | Disposed |
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Ankran Biotech Pvt Ltd and 3 others | Disposed |
| District court, Dumka, Jharkhand | Court case (Drugs and Cosmetics) | Filed against the company by an individual | Pending |
To see the full case history of Jips Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jips Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Jips Pharmaceuticals Private Limited has a workforce of 16 employees on its EPFO records as of Feb 28, 2025, across 1 active EPFO establishment.
Employee count
16
Active EPFO establishments
1
Employee growth
-60%
GST
Jips Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 03AADCJ8712C1Z1 | Punjab | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jips Pharmaceuticals Private Limited, buy the company report.
Recent activity
Jips Pharmaceuticals Private Limited has 4 board changes on record since 2017: 4 appointments. The latest: Irvandeep Kaur was appointed as Director on 17 Jan 2017.
AGM
Jips Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Jips Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Chandigarh.
Appointed
Irvandeep Kaur was appointed as Director.
Appointed
Supreet Singh was appointed as Director.
Appointed
Jagdeep Singh was appointed as Director.
Appointed
Parvinder Jit Singh was appointed as Director.
Incorporation
13 Jan 2017
Jips Pharmaceuticals Private Limited was registered on 13 Jan 2017 with Roc Chandigarh & aged 9 years 9 months as per MCA records.
Frequently asked questions
Jips Pharmaceuticals is an active private limited company based in Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 January 2017 (9+ years old) and is registered under CIN U24304CH2017PTC041344.
Jips Pharmaceuticals has 4 current directors:
- Irvandeep Kaur - Director
- Supreet Singh - Director
- Jagdeep Singh - Director
- Parvinder Jit Singh - Director
The latest financial statements of Jips Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Jips Pharmaceuticals is 03AADCJ8712C1Z1, registered in Punjab.
The CIN (Corporate Identification Number) of Jips Pharmaceuticals is U24304CH2017PTC041344. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jips Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 1 is pending.
Jips Pharmaceuticals was incorporated on 13 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Jips Pharmaceuticals by revenue are Synac Pharmaceuticals Private Limited, Anthea Pharma Private Limited, Lifesticks Pharmaceuticals Private Limited, Sain Medicaments Private Limited, Quixotic Pharma Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Irvandeep Kaur was appointed as Director on 17 Jan 2017. Supreet Singh was appointed as Director on 17 Jan 2017. Jagdeep Singh was appointed as Director on 13 Jan 2017. Jips Pharmaceuticals has 4 board changes on record in total.
Yes, Jips Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Jips Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-PB-20-0025407).